After receiving her Ph.D. degree from the University of British Columbia, Vancouver, BC, Canada, and postdoc training at the Fred Hutchinson Cancer Research Center (FHCRC), Jennifer Wu joined the Faculty of Medicine at the University of Washington (UW) and became a Member of the UW/FHCRC Cancer Consortium. She served as the Associated Professor at the University of Washington till she accepted the Appointment at the Medical University of South Carolina and Hollings Cancer Center. She is currently an Associated Professor in the Department of Microbiology and Immunology at the Medical University of South Carolina and a Member of the Hollings Cancer Center. She is also Affiliated Associate Professor at the University of Washington. She has been serving Immunology and Oncology Study Sections for the NIH/NCI and DOD-USARMC multiple times. Wu is currently elected as the Committee Chair of Cancer Community Practice of Federation of Clinical Immunology Society. She has been serving the Editorial Board of ISRN Urology since 2011. Research in Wu’s laboratory has defined for the first time that prostate tumor progression is associated with prostate tumor immunoediting of the innate NK-cell antitumor immunity. The other area of her research is tissue microenvironment, namely, inflammation, in prostate tumor initiation and progression. Wu’s laboratory has shown for the first time that the multifunctional cytokine IL-6 can develop into prostate tumor and further progress to metastasis through the autocrine activation of type I insulin-like growth factor receptor (IGF-IR).
Biography Updated on 1 July 2013